Value through InnovationMay 27 2015

Boehringer Ingelheim Press Releases

See the latest Boehringer Ingelheim press releases. To quickly find all press releases on a specific topic, please use the search.

Press Release Archive

back 1 2 3 4 5 6 7 8 9 10

Boehringer Ingelheim and Lilly Diabetes Alliance to Present Data from 35 Studies at the American Diabetes Association’s 75th Scientific Sessions®


FDA Approves Boehringer Ingelheim’s STIOLTOTM RESPIMAT® Inhalation Spray as Once-Daily Maintenance Treatment for COPD


New Data Analyses on Investigational Tiotropium/Olodaterol Respimat® Showed Greater Lung Function Improvement Compared to Tiotropium and Olodaterol Alone


BIPI Statement On The Update To The ATS/ERS/JRS/ALAT Clinical Practice Guidelines For The Treatment Of Idiopathic Pulmonary Fibrosis


Boehringer Ingelheim Presents New Data and Analyses Reinforcing the Safety and Efficacy of OFEV® (nintedanib) Capsules


Boehringer Ingelheim Awards Grants to Support Innovative Research on Genetic Markers in Atrial Fibrillation and Treatment Adherence with Electronic Alert Program


Boehringer Ingelheim showcases expanding presence in lung cancer at ASCO with new data including presentation of Gilotrif® (afatinib) overall survival results for squamous cell carcinoma of the lung


Boehringer Ingelheim and Sutter Health Establish Research Collaboration to Improve Patient Care


Boehringer Ingelheim to Present 29 Abstracts at the Annual American Thoracic Society International Conference


FDA Grants Priority Review to Boehringer Ingelheim’s Biologics License Application for Idarucizumab*

back 1 2 3 4 5 6 7 8 9 10